New research shows that mothers who follow a Western diet—characterized by consumption of foods that are high in fat and sugar and low in fresh ingredients—during pregnancy may have an increased risk of having children with neurodevelopmental disorders such as attention-deficit/hyperactivity disorder (ADHD) and autism. The findings appeared in Nature Metabolism.
Advertisement
A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO.
Researchers assessed ICD gene expressions to predict immunotherapy response and immune cell infiltration.
A study examined whether kidney function decline accelerated after COVID-19 versus other respiratory infections.
Thrombosis history was not predictive of overall survival in patients with pulmonary hypertension risk and PV, a study found.
What were the effects of moving calcimimetics from the TDAPA to an increased bundled payment?
Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D.
Food insecurity is linked with an increased risk of developing heart disease.
Is coprescription of gabapentinoids with other psychoactive medications associated with altered mental status and falls?
DocWire Content Partners
Powered by DocWire News
The Latest From GI Oncology Now
Suvemcitug, envafolimab, and FOLFIRI may serve as a new second-line treatment option for cold tumors.
KRASG12C inhibitors can have reduced efficacy in patients with alterations in KRAS, EGFR, and other genes.
Complete responders with HCC have prolonged survival and durable disease control even after therapy has been discontinued.
The primary objective of median PFS was significantly longer for patients treated with 177Lu-edotreotide.
The safety profile of the combination was consistent with known profiles, and no new safety findings were observed.
Older patients in their 70s with extrahepatic CCA have a higher rate of choledocholithiasis.
The Latest From Heme Today
Thrombosis history was not predictive of overall survival in patients with pulmonary hypertension risk and PV, a study found.
The oral agent exhibited promising hemoglobin response performance and safety in this stage of an ongoing phase 2/3 study.
The first-in-class agent operates by increasing both von Willebrand factor and factor VIII levels in patients.
Immune thrombocytopenia featured most prominently at the Meeting but new data was presented for several forms of the disease.
Imetelstat is indicated for patients with lower-risk MDS who had an unsatisfactory response to or are ineligible to ESAs.
In findings arterial thrombosis carried worse overall survival than venous thrombosis in this patient population.